Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Position HTO Multicenter NIS (Position HTO)

This study has been completed.
Information provided by:
Aesculap AG Identifier:
First received: April 27, 2009
Last updated: July 21, 2011
Last verified: July 2011
Evaluation of the Position HTO system in patients with unicompartmental medial arthrosis after open wedge high tibial osteotomy

Condition Intervention
Medial Monocompartmental Osteoarthritis of the Knee
Device: Position HTO system

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Study on Quality of Life in Patients With Unicompartmental Arthrosis After High Tibial Osteotomy With the Position HTO(R) System

Resource links provided by NLM:

Further study details as provided by Aesculap AG:

Primary Outcome Measures:
  • Patient health status improvement assessed by IKDC 2000 subjective knee score [ Time Frame: 1 year after HTO ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Improvement of further scores: Tegner Activity Score, Lysholm-Gillquist Score, Cincinnati-Sportsmedicine and Orthopaedic Center-Score, IKDC 2000 objective knee score, Hospital for Special Surgery Score (HSS) [ Time Frame: 1 year after HTO ] [ Designated as safety issue: No ]

Enrollment: 221
Study Start Date: July 2007
Study Completion Date: June 2010
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
HTO cohort
Device: Position HTO system
open wedge high tibial osteotomy


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
adult patients

Inclusion: Varus deformity between 0 - 20°, Isolated medial arthrosis ≥ level 2 (K&L) OR a congenital deformity OR chondromalacia ≥ level 2 (ICRS), Lateral cartilaginous tissue damage ≤ level 1(K&L), Intact lateral meniscus, Age ≥ 18 years, Range of Motion at least 0° - 0° - 130°, Patella/ sliding plane without signifikant signs of arthrosis, Stable joint OR possibility of intraoperative balancing of the tendon tension;

Exclusion: Clinically relevant disorders of bone metabolism, Aktive infection, Adipositas (BMI ≥ 35), Rheumatoid arthritis, Osteomyelitis in the tibia, No availibility for follow-up examinations

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00889304

Orthopädie Harthausen
Bad Aibling, Germany, 83043
Caritas-Krankenhaus Bad Mergentheim
Bad Mergentheim, Germany, 97980
Universitätsklinikum Regensburg
Regensburg, Germany, 93053
Winghofer Medicum
Rottenburg, Germany, 72108
BGU Tübingen
Tübingen, Germany, 72076
Sponsors and Collaborators
Aesculap AG
Principal Investigator: Jürgen Fritz, Dr. Winghofer Medicum
  More Information

Responsible Party: Viktor Breul, Aesculap AG Identifier: NCT00889304     History of Changes
Other Study ID Numbers: AAG-O-H-0702 
Study First Received: April 27, 2009
Last Updated: July 21, 2011
Health Authority: Germany: Ethics Commission

Keywords provided by Aesculap AG:
HTO, high tibial osteotomy, open wedge, medial arthritis

Additional relevant MeSH terms:
Osteoarthritis, Knee
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases processed this record on October 21, 2016